Lataa...
The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment
Efavirenz (EFV) is an anti-HIV drug, and cytochrome P450 46A1 (CYP46A1) is the major brain cholesterol hydroxylase. Previously, we discovered that EFV activates CYP46A1 and improves behavioral performance in 5XFAD mice, an Alzheimer’s disease model. Herein, the unbiased omics and other approaches we...
Tallennettuna:
| Julkaisussa: | FASEB J |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Federation of American Societies for Experimental Biology
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6662980/ https://ncbi.nlm.nih.gov/pubmed/31063705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201900092R |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|